We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$540M
AUM Growth
-$17.9M
Cap. Flow
-$41M
Cap. Flow %
-7.6%
Top 10 Hldgs %
26.96%
Holding
716
New
62
Increased
152
Reduced
248
Closed
35

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$21.8M
2
STLA icon
Stellantis
STLA
+$20.9M
3
EPHE icon
iShares MSCI Philippines ETF
EPHE
+$11.4M
4
RACE icon
Ferrari
RACE
+$10.4M
5
DB icon
Deutsche Bank
DB
+$9.96M

Sector Composition

Rank Sector Weight
1 Financials 13.08%
2 Consumer Discretionary 12.84%
3 Technology 8.88%
4 Materials 7.83%
5 Industrials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBS icon
1
UBS Group
UBS
$170B
$34.7M 6.43%
2,654,394
-1,829,861
-41% -$21.8M
EEM icon
2
iShares MSCI Emerging Markets ETF
EEM
$28B
$22.1M 4.1%
484,115
+226,837
+88% +$9.74M
EWT icon
3
iShares MSCI Taiwan ETF
EWT
$10B
$15.4M 2.85%
372,835
+118,215
+46% +$4.66M
RSX
4
DELISTED
VanEck Russia ETF
RSX
$14.1M 2.61%
542,029
-104,743
-16% -$2.54M
RACE icon
5
Ferrari
RACE
$63.3B
$13M 2.4%
82,399
-64,540
-44% -$10.4M
EWM icon
6
iShares MSCI Malaysia ETF
EWM
$305M
$10.4M 1.93%
366,522
+366,505
+2,155,912% +$10.3M
MCHI icon
7
iShares MSCI China ETF
MCHI
$6.04B
$9.59M 1.78%
143,735
+143,230
+28,362% +$8.57M
IBM icon
8
IBM
IBM
$202B
$9M 1.67%
+68,905
New +$8.96M
STLA icon
9
Stellantis
STLA
$16.5B
$8.96M 1.66%
729,277
-1,442,162
-66% -$20.9M
TUR icon
10
iShares MSCI Turkey ETF
TUR
$206M
$8.29M 1.54%
285,135
-131,795
-32% -$3.4M
LIN icon
11
Linde
LIN
$237B
$7.99M 1.48%
37,464
+34,949
+1,390% +$7.04M
CNH
12
CNH Industrial
CNH
$13.8B
$7.8M 1.44%
820,300
-451,029
-35% -$4.24M
UBS icon
13
PUT
UBS Group
UBS
$170B
$7.43M 1.38%
82,086
-17,151
-17% -$204K
FCX icon
14
Freeport-McMoran
FCX
$90B
$7.19M 1.33%
+554,426
New +$6.09M
INTC icon
15
Intel
INTC
$466B
$6.46M 1.2%
109,586
+29,465
+37% +$1.65M
GLD icon
16
SPDR Gold Trust
GLD
$131B
$6.21M 1.15%
42,412
-14,199
-25% -$1.98M
CSCO icon
17
Cisco
CSCO
$450B
$6.16M 1.14%
128,249
+55,946
+77% +$2.6M
PAAS icon
18
Pan American Silver
PAAS
$18.6B
$5.95M 1.1%
261,770
+243,850
+1,361% +$4.52M
SPY icon
19
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$5.61M 1.04%
17,097
+1,097
+7% +$338K
MRK icon
20
Merck
MRK
$324B
$5M 0.93%
57,307
+1,656
+3% +$136K
V icon
21
Visa
V
$677B
$5M 0.93%
25,007
+5,093
+26% +$918K
STLA icon
22
PUT
Stellantis
STLA
$16.5B
$4.99M 0.93%
10,523
-4,457
-30% -$64.4K
DB icon
23
Deutsche Bank
DB
$66.3B
$4.91M 0.91%
576,469
-1,328,280
-70% -$9.96M
T icon
24
AT&T
T
$165B
$4.89M 0.91%
170,939
+61,694
+56% +$1.78M
PEP icon
25
PepsiCo
PEP
$186B
$4.67M 0.86%
33,543
+9,379
+39% +$1.28M

Similar funds

Exane Derivatives's Q4 2019 Portfolio in Review

As of Q4 2019, Exane Derivatives held 716 positions worth $540M, down 3.2% from $558M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Exane Derivatives withdrew a net $41M in Q4 2019, closing 35 positions and reducing 248 holdings. Its most notable exit was iShares MSCI Indonesia ETF, an estimated $6.83M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Exane Derivatives opened a new position in IBM worth $9M.

  • Exane Derivatives's largest Q4 2019 buy was IBM: 68,905 shares worth $9M.
  • Exane Derivatives added most to iShares MSCI Malaysia ETF in Q4 2019, an estimated $10.3M increase.
  • Exane Derivatives's biggest Q4 2019 reduction was UBS Group, cutting an estimated $21.8M.
  • Exane Derivatives fully exited iShares MSCI Indonesia ETF in Q4 2019, selling an estimated $6.83M.
  • Exane Derivatives's ten largest holdings make up 27% of its $540M portfolio in Q4 2019.
  • Exane Derivatives opened 62 new positions and closed 35 in Q4 2019.
  • Exane Derivatives's portfolio value fell 3.2% quarter-over-quarter to $540M.

Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.